EdgarLookup

Apimeds Pharmaceuticals US, Inc. — EFFECT Filings

2 EFFECT filings on record

This page lists all EFFECT filings submitted to the SEC by Apimeds Pharmaceuticals US, Inc. (APUS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Apimeds Pharmaceuticals US, Inc. has filed 2 EFFECT documents with the SEC since 2024. To view all SEC filings by Apimeds Pharmaceuticals US, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 3 3/A 4 4/A 424B4 425 8-A12B 8-K 8-K/A CERT CORRESP DEFM14C DRS DRS/A DRSLTR EFFECT FWP NT 10-K NT 10-Q POS AM PREM14C S-1 S-1/A S-8 SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G UPLOAD
Form Description Accession Number Filed Period
EFFECT — 9999999995-25-001413 May 5, 2025 —
EFFECT — 9999999995-25-000387 Feb 11, 2025 —